![Eamonn Connolly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eamonn Connolly
Keine laufenden Positionen mehr
Profil
Eamonn Connolly worked as the Head of the Research Department at BioGaia AB from 2010 to 2011.
He then served as the Chief Scientific Officer at Infant Bacterial Therapeutics AB from 2013 to 2021.
Dr. Connolly obtained an undergraduate degree from The University of Manchester and a doctorate degree from the University of Manchester Institute of Science & Technology.
Ehemalige bekannte Positionen von Eamonn Connolly
| Unternehmen | Position | Ende |
|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
| BIOGAIA AB | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Eamonn Connolly
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
BioGaia AB
 BioGaia AB Pharmaceuticals: OtherHealth Technology Develops health care products such as foods with healthy additives and provides pharmaceutical research services | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manchester Institute of Science & Technology
 University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infant Bacterial Therapeutics AB
 Infant Bacterial Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of gastroschisis | Health Technology |
Wählen Sie MarketScreener 
